Clinical Trial Update: Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous tenecteplase given before interhospital transfer for acute basilar artery occlusion within 4.5 to 24 hours is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basilar Artery Occlusion
• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Acute Ischemic Stroke, Basilar Artery Occlusion | Phase 4 | Status: RECRUITING